Leading the way to a cure

ALR Target Identification in Lupus - 2010 Grantees

In 2010, the ALR is committing funding to 9 Target Identification in Lupus (TIL) grants: 6 new research grants and 3 renewed grants. Most TIL investigators are receiving research grants of approximately $450,000 over two years. The ALR is also proud to provide ongoing support for researchers in their second year of TIL funding and for additional, extended TIL projects.

Below is a list of 2010 Grantees:

Eisenberg, Robert, MD
University of Pennsylvania
Distal Ig Receptor Revision in the Production of SLE Autoantibodies       

Jacob, Chaim, MD, PhD   
USC/University of Southern California
Targeted DNA capture and parallel sequencing to identify causal mutation       

Kelley, Vicki, PhD
Brigham and Women's Hospital, Inc.
Colony Stimulating Factor 1: A TherapeuticTarget for Lupus Nephritis   

Lu, Kun Ping, MD, PhD
Beth Israel Deaconess Medical Center
The prolyl isomerase Pin1: a novel therapeutic target in SLE     

Niewold, Timothy, MD
The University of Chicago
Role of ILT Receptors in Human Lupus   

Elkon, Keith, MD  
University of Washington
Lysis of Immunostimulatory Nucleoproteins in SLE 

Perl, Andras, MD, PhD
SUNY Upstate Medical University
Mitochondrial Hyperpolarization in Lupus T Cells   

Rifkin, Ian, MD, PhD
Boston Medical Center Corporation
Adiponectin and adiponectin receptors in lupus and lupus atherosclerosis   

2009 TIL Grantees

1.5 million

people in the U.S. have Lupus.

90 million

dollars committed to lupus research by the Alliance for Lupus Research.

We're walking across the United States to raise awareness and funds for lupus research.

Can't make it? Join our National Virtual Walk to participate anytime, anywhere.

Show your support by visiting the Alliance for Lupus Research online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.

Powered by Convio
nonprofit software